Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-15T21:16:45.836Z Has data issue: false hasContentIssue false
  • English
  • Français

Advances in molecular genetics for pulmonary atresia

Published online by Cambridge University Press:  22 September 2016

Manchen Gao ,
Xiaomin He  and
Jinghao Zheng
Manchen Gao
Affiliation:
Department of Cardiothoracic Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Xiaomin He*
Affiliation:
Department of Cardiothoracic Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Jinghao Zheng*
Affiliation:
Department of Cardiothoracic Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
*
Correspondence to: X. He & J. Zheng, Department of Cardiothoracic Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Shanghai, 200127, China. Tel: +86 21 3862 6161; Fax: +86 21 3862 6161; E-mail: [email protected]; [email protected]
Correspondence to: X. He & J. Zheng, Department of Cardiothoracic Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Shanghai, 200127, China. Tel: +86 21 3862 6161; Fax: +86 21 3862 6161; E-mail: [email protected]; [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Genetic and environmental factors may be similar in certain CHD. It has been widely accepted that it is the cumulative effect of these risk factors that results in disease. Pulmonary atresia is a rare type of complex cyanotic CHD with a poor prognosis. Understanding the molecular mechanism of pulmonary atresia is essential for future diagnosis, prevention, and therapeutic approaches. In this article, we reviewed several related copy number variants and related genetic mutations, which were identified in patients with pulmonary atresia, including pulmonary atresia with ventricular septal defect and pulmonary atresia with intact ventricular septum.

Keywords

CHDpulmonary atresiacopy number variantsgene mutations
Type
Review Articles
Information
Cardiology in the Young , Volume 27 , Issue 2 , March 2017 , pp. 207 - 216
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kahr, PC, Diller, GP. Almanac 2014: congenital heart disease. Heart 2015; 101: 65–71.Google Scholar
2. Cowan, JR, Ware, SM. Genetics and genetic testing in congenital heart disease. Clin Perinatol 2015; 42: 373–393.Google Scholar
3. van der Bom, T, Zomer, AC, Zwinderman, AH, Meijboom, FJ, Bouma, BJ, Mulder, BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011; 8: 50–60.Google Scholar
4. Momma, K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol 2010; 105: 1617–1624.CrossRefGoogle ScholarPubMed
5. Abid, D, Elloumi, A, Abid, L, et al. Congenital heart disease in 37,294 births in Tunisia: birth prevalence and mortality rate. Cardiol Young 2014; 24: 866–871.Google Scholar
6. Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–1900.Google Scholar
7. Zampi, JD, Hirsch-Romano, JC, Goldstein, BH, Shaya, JA, Armstrong, AK. Hybrid approach for pulmonary atresia with intact ventricular septum: early single center results and comparison to the standard surgical approach. Catheter Cardiovasc Interv 2014; 83: 753–761.Google Scholar
8. Fesslova, V, Brankovic, J, Lalatta, F, et al. Recurrence of congenital heart disease in cases with familial risk screened prenatally by echocardiography. J Pregnancy 2011; 2011: 368067.Google Scholar
9. Sun, X, Meng, Y, You, T, et al. Association of growth/differentiation factor 1 gene polymorphisms with the risk of congenital heart disease in the Chinese Han population. Mol Biol Rep 2013; 40: 1291–1299.Google Scholar
10. Lee, CN, Su, YN, Cheng, WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand 2005; 84: 1134–1140.CrossRefGoogle ScholarPubMed
11. Bentham, J, Bhattacharya, S. Genetic mechanisms controlling cardiovascular development. Ann N Y Acad Sci 2008; 1123: 10–19.CrossRefGoogle ScholarPubMed
12. Gelb, BD, Chung, WK. Complex genetics and the etiology of human congenital heart disease. Cold Spring Harb Perspect Med 2014; 4: a013953.Google Scholar
13. Silversides, CK, Lionel, AC, Costain, G, et al. Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genet 2012; 8: e1002843.Google Scholar
14. Lander, J, Ware, SM. Copy number variation in congenital heart defects. Curr Genet Med Rep 2014; 2: 168–178.CrossRefGoogle Scholar
15. Soemedi, R, Wilson, IJ, Bentham, J, et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet 2012; 91: 489–501.Google Scholar
16. Warburton, D, Ronemus, M, Kline, J, et al. The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet 2014; 133: 11–27.CrossRefGoogle ScholarPubMed
17. Tomita-Mitchell, A, Mahnke, DK, Struble, CA, et al. Human gene copy number spectra analysis in congenital heart malformations. Physiol Genomics 2012; 44: 518–541.Google Scholar
18. Serra-Juhe, C, Rodriguez-Santiago, B, Cusco, I, et al. Contribution of rare copy number variants to isolated human malformations. PLoS One 2012; 7: e45530.Google Scholar
19. Xie, L, Chen, JL, Zhang, WZ, et al. Rare de novo copy number variants in patients with congenital pulmonary atresia. PLoS One 2014; 9: e96471.Google Scholar
20. Nagamani, SC, Erez, A, Bader, P, et al. Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet 2011; 19: 280–286.Google Scholar
21. Prakash, SK, LeMaire, SA, Guo, DC, et al. Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections. Am J Hum Genet 2010; 87: 743–756.Google Scholar
22. Pannu, H, Tran-Fadulu, V, Papke, CL, et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 2007; 16: 2453–2462.Google Scholar
23. Xu, YJ, Wang, J, Xu, R, et al. Detecting 22q11.2 deletion in Chinese children with conotruncal heart defects and single nucleotide polymorphisms in the haploid TBX1 locus. BMC Med Genet 2011; 12: 169.Google Scholar
24. Christensen, KE, Zada, YF, Rohlicek, CV, et al. Risk of congenital heart defects is influenced by genetic variation in folate metabolism. Cardiol Young 2013; 23: 89–98.Google Scholar
25. Cario, H, Smith, DE, Blom, H, et al. Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am J Hum Genet 2011; 88: 226–231.Google Scholar
26. Kozyraki, R. Cubilin, a multifunctional epithelial receptor: an overview. J Mol Med 2001; 79: 161–167.Google Scholar
27. Tsaroucha, AK, Chatzaki, E, Lambropoulou, M, et al. Megalin and cubilin in the human gallbladder epithelium. Clin Exp Med 2008; 8: 165–170.Google Scholar
28. Song, K, Backs, J, McAnally, J, et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 2006; 125: 453–466.Google Scholar
29. Soemedi, R, Topf, A, Wilson, IJ, et al. Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 2012; 21: 1513–1520.Google Scholar
30. Christiansen, J, Dyck, JD, Elyas, BG, et al. Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circ Res 2004; 94: 1429–1435.CrossRefGoogle Scholar
31. Mefford, HC, Sharp, AJ, Baker, C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008; 359: 1685–1699.Google Scholar
32. Holler, KL, Hendershot, TJ, Troy, SE, Vincentz, JW, Firulli, AB, Howard, MJ. Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expression and outflow tract development. Dev Biol 2010; 341: 291–304.Google Scholar
33. Guida, V, Ferese, R, Rocchetti, M, et al. A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot. Eur J Hum Genet 2013; 21: 69–75.Google Scholar
34. Izumi, K, Lippa, AM, Wilkens, A, Feret, HA, McDonald-McGinn, DM, Zackai, EH. Congenital heart defects in oculodentodigital dysplasia: report of two cases. Am J Med Genet A 2013; 161A: 3150–3154.Google Scholar
35. Mohapatra, B, Casey, B, Li, H, et al. Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Hum Mol Genet 2009; 18: 861–871.Google Scholar
36. Zhang, Y, Zhang, XF, Gao, L, et al. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction. Biochim Biophys Acta 2014; 1842: 232–244.Google Scholar
37. Wessels, MW, Willems, PJ. Genetic factors in non-syndromic congenital heart malformations. Clin Genet 2010; 78: 103–123.Google Scholar
38. Verkleij-Hagoort, A, Bliek, J, Sayed-Tabatabaei, F, Ursem, N, Steegers, E, Steegers-Theunissen, R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am J Med Genet A 2007; 143A: 952–960.Google Scholar
39. Wang, W, Hou, Z, Wang, C, Wei, C, Li, Y, Jiang, L. Association between 5, 10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and congenital heart disease: a meta-analysis. Meta Gene 2013; 1: 109–125.Google Scholar
40. Xu, J, Xu, X, Xue, L, et al. MTHFR c.1793G>A polymorphism is associated with congenital cardiac disease in a Chinese population. Cardiol Young 2010; 20: 318–326.Google Scholar
41. Sayin Kocakap, BD, Sanli, C, Cabuk, F, Koc, M, Kutsal, A. Association of MTHFR A1298C polymorphism with conotruncal heart disease. Cardiol Young 2015; 25: 1326–1331.Google Scholar
42. Vincentz, JW, Barnes, RM, Firulli, AB. Hand factors as regulators of cardiac morphogenesis and implications for congenital heart defects. Birth Defects Res A Clin Mol Teratol 2011; 91: 485–494.Google Scholar
43. Risebro, CA, Smart, N, Dupays, L, Breckenridge, R, Mohun, TJ, Riley, PR. Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart. Development 2006; 133: 4595–4606.Google Scholar
44. Srivastava, D, Gottlieb, PD, Olson, EN. Molecular mechanisms of ventricular hypoplasia. Cold Spring Harb Symp Quant Biol 2002; 67: 121–125.Google Scholar
45. VanDusen, NJ, Casanovas, J, Vincentz, JW, et al. Hand2 is an essential regulator for two Notch-dependent functions within the embryonic endocardium. Cell Rep 2014; 9: 2071–2083.CrossRefGoogle ScholarPubMed
46. Reamon-Buettner, SM, Ciribilli, Y, Inga, A, Borlak, J. A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Hum Mol Genet 2008; 17: 1397–1405.Google Scholar
47. England, J, Loughna, S. Heavy and light roles: myosin in the morphogenesis of the heart. Cell Mol Life Sci 2013; 70: 1221–1239.Google Scholar
48. Posch, MG, Waldmuller, S, Muller, M, et al. Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One 2011; 6: e28872.Google Scholar
49. Granados-Riveron, JT, Ghosh, TK, Pope, M, et al. Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects. Hum Mol Genet 2010; 19: 4007–4016.Google Scholar
50. Arrington, CB, Bleyl, SB, Matsunami, N, et al. Exome analysis of a family with pleiotropic congenital heart disease. Circ Cardiovasc Genet 2012; 5: 175–182.Google Scholar
51. Arrington, CB, Bleyl, SB, Brunelli, L, Bowles, NE. Family-based studies to identify genetic variants that cause congenital heart defects. Future Cardiol 2013; 9: 507–518.Google Scholar
52. Theis, JL, Zimmermann, MT, Evans, JM, et al. Recessive MYH6 mutations in hypoplastic left heart with reduced ejection fraction. Circ Cardiovasc Genet 2015; 8: 564–571.Google Scholar
53. Kalogirou, S, Malissovas, N, Moro, E, Argenton, F, Stainier, DY, Beis, D. Intracardiac flow dynamics regulate atrioventricular valve morphogenesis. Cardiovasc Res 2014; 104: 49–60.Google Scholar
54. Reamon-Buettner, SM, Borlak, J. HEY2 mutations in malformed hearts. Hum Mutat 2006; 27: 118.Google Scholar
55. Donovan, J, Kordylewska, A, Jan, YN, Utset, MF. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 2002; 12: 1605–1610.Google Scholar
56. Fischer, A, Klamt, B, Schumacher, N, et al. Phenotypic variability in Hey2 -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm Genome 2004; 15: 711–716.Google Scholar
57. Sarkozy, A, Conti, E, D’Agostino, R, et al. ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia. Am J Med Genet A 2005; 133A: 68–70.Google Scholar
58. Fischer, A, Steidl, C, Wagner, TU, et al. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 2007; 100: 856–863.Google Scholar
59. Geng, J, Picker, J, Zheng, Z, et al. Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. BMC Genomics 2014; 15: 1127.Google Scholar
60. Breckpot, J, Thienpont, B, Peeters, H, et al. Array comparative genomic hybridization as a diagnostic tool for syndromic heart defects. J Pediatr 2010; 156: 810–817; 817. e811–e817. e814.Google Scholar
61. Mardis, ER. A decade’s perspective on DNA sequencing technology. Nature 2011; 470: 198–203.Google Scholar